Journal clubs offer the opportunity for 1 or 2 of the selected article’s authors to present a summary of their paper, which is then followed by a discussion and chance for participants to ask questions. Currently, journal club invitations are extended to ISPOR special interest group members and student members. Attending journal clubs are a benefit of being a member of a special interest group. To join a special interest group click here. Please contact us for more information on participating in future journal clubs.
It is advised that you read the article prior to participating in a live journal club or watching the discussion on demand.
Previously Recorded Sessions
- Use of Real- World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design - June 2022
- Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy with or without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data - June 2022
- Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients - May 2022
- Taking Into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions within Patient Preference Studies”- March 2022
- Fulfilling the Promise of Artificial Intelligence in the Health Sector: Let’s Get Real - March 2022
- Racial, Ethnic & Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma - March 2022
- Cost-effectiveness of magnetic resonance imaging in prostate cancer screening: A microsimulation study- March 2022
- Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework - November 2021
- Examining equity effects of health interventions in cost-effectiveness analysis: A systematic review - November 2021
- Using Real-World Evidence For US Payer Coverage Decision-Making- November 2021
- Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China - October 2021
- Intrapatient Comparisons Of Efficacy In A Single-Arm Trial Of Entrectinib In Tumour-Agnostic Indication - July 2021
- A review of methodological considerations for economic evaluations of gene therapies and their application in literature - April 2021
- Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada - March 2021
- Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments - March 2021
- Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries - May 2020
- Long-term Survival and Cost-effectiveness Associated with Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphom - January 2020
Health Preference Research Special Interest Group
Title of Article: "Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China"
DOI: https://doi.org/10.1016/j.jval.2020.06.010
Date: October 2021
Back to Top
Open Source Models Special Interest Group
Title of Article: “Examining equity effects of health interventions in cost-effectiveness analysis: A systematic review”
DOI: 10.1016/j.jval.2020.10.010
Date: November 2021
Back to TopTitle of Article: Use of Real- World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Date: June 2022
Back to Top